| 000 | 01717 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517222235.0 | ||
| 264 | 0 | _c20190711 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1664-3224 | ||
| 024 | 7 |
_a10.3389/fimmu.2018.01030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaudin, Olivier | |
| 245 | 0 | 0 |
_aGliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients. _h[electronic resource] |
| 260 |
_bFrontiers in immunology _c2018 |
||
| 300 |
_a1030 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 |
_aAutoantigens _ximmunology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMucous Membrane _xdrug effects |
| 650 | 0 | 4 |
_aPemphigoid, Benign Mucous Membrane _xchemically induced |
| 650 | 0 | 4 |
_aPemphigoid, Bullous _xchemically induced |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSkin _ximmunology |
| 700 | 1 | _aSeta, Vannina | |
| 700 | 1 | _aAlexandre, Marina | |
| 700 | 1 | _aBohelay, Gérôme | |
| 700 | 1 | _aAucouturier, Françoise | |
| 700 | 1 | _aMignot-Grootenboer, Sabine | |
| 700 | 1 | _aIngen-Housz-Oro, Saskia | |
| 700 | 1 | _aBernardeschi, Céline | |
| 700 | 1 | _aSchneider, Pierre | |
| 700 | 1 | _aMellottee, Benoît | |
| 700 | 1 | _aCaux, Frédéric | |
| 700 | 1 | _aProst-Squarcioni, Catherine | |
| 773 | 0 |
_tFrontiers in immunology _gvol. 9 _gp. 1030 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2018.01030 _zAvailable from publisher's website |
| 999 |
_c28509533 _d28509533 |
||